
Top Stories
Pharma Lobby Readies Legal Firepower for Drug Pricing Measures
Measures to lower prescription drug prices will inevitably end up being challenged by pharmaceutical companies, even as they have yet to become law, attorneys say.
Consumer Class Actions May Founder Due to Eleventh Circuit Split
A majority of the Eleventh Circuit voted not to revisit a 2020 opinion prohibiting incentive awards for class representatives, solidifying a new circuit split over whether a pair of 19th century Supreme Court cases have always barred the payments.
Climate Bill Targets Transmission to Unjam Clean Energy Backlog
Senate Democrats’ climate bill includes $3 billion in loans and grants for electric transmission projects—money that, in addition to tax incentives for electricity generators, would break down a significant barrier to a large-scale clean energy rollout, advocates said.
AI-Assisted Inventions Could Spur New Patent Litigation Wave
The amount of human involvement needed to secure a patent when artificial intelligence is used to create an invention remains up in the air after a Federal Circuit decision shutting down the possibility of solo AI inventorship.
Hospitals Fear Abortion Bans Will Worsen Staff Shortages
Some doctors don’t even want to think about taking jobs in Texas, Wyoming, or other states with strict abortion bans, raising questions about how hospitals will recruit and retain medical staff in a post-Roe country.
Trump Under Intense Legal Scrutiny After FBI Searches Mar-a-Lago
Steven Davis and the Rise and Fall of Dewey & LeBoeuf
Up Next

Prince, Andy Warhol, and Fair Use at the Supreme Court

Will the Global Minimum Tax End the Race to the Bottom?

Legally Rigging Elections: Redistricting, a Brief History
Podcasts

A New Documentary on Dewey & LeBoeuf's Implosion

Democrats Gain Confidence, But It May Not Last
